首页>
外国专利>
COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND THEREFORE CONDITIONAL SUFFERING AND TREATMENT OF INCREASING THE GLP-1 MIRROR IN BLOOD-IMPROVED SUDDEN
COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND THEREFORE CONDITIONAL SUFFERING AND TREATMENT OF INCREASING THE GLP-1 MIRROR IN BLOOD-IMPROVED SUDDEN
展开▼
机译:联合疗法治疗糖尿病,并在改善血液的突然情况下有条件地给予和增加GLP-1镜面治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention concerns combination of an amount of a GPR1 19 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-I level in a subject over that provided by the amount of the GPR1 19 agonist or the amount of the DPP-FV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-I level. The present invention also relates to the use of a G protein-coupled receptor to screen for GLP-I secretagogues.
展开▼